INSULIN ANTILIPOLYTIC (PREVENTS FAT LOSS)
December 8, 2023DYSBIOSIS
December 8, 2023
- Sulfonylureas
- Sulfonylureas in NIDDM
- Sulfonylureas.
- Sulfonylureas
- Sulfonylureas Why, Which, and How?
- Sulfonylureas and Sulfonylthioureas.
- Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials
- Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6. 2 mutations
- State of the art paper Sulfonylureas and their use in clinical practice
- Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin
- Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin
- Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis
- Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas
- Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations
- Individual sulfonylureas and serious hypoglycemia in older people
- Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.
- Glucose, Sulfonylureas, and Neurotransmitter Release: Role of ATP-Sensitive K+ Channels
- Variation in TCF7L2 Influences Therapeutic Response to Sulfonylureas: A GoDARTs Study
- Rates of hypoglycemia in users of sulfonylureas
- Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin
- The pharmacology of sulfonylureas
- The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells.
- Cardiovascular safety of sulfonylureas: a meta‐analysis of randomized clinical trials
- Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K (ATP) channels.
- Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality? A meta-analysis of observational …
- Mortality risk among sulfonylureas: a systematic review and network meta-analysis
- Comparison of efficacy, secondary failure rate, and complications of sulfonylureas
- Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with …
- The place of sulfonylureas in the therapy for type 2 diabetes mellitus
- Mechanisms of the glycaemic effects of sulfonylureas
- Sulfonylureas and the risks of cardiovascular events and death: a methodological meta-regression analysis of the observational studies
- Loss‐of‐function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go‐DARTS study
- Extrapancreatic effects of sulfonylureas—a comparison between glimepiride and conventional sulfonylureas
- Clinical observation on trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus
- Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
- Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with …
- Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide
- PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic β cells
- Tissue-specific effects of sulfonylureas: lessons from studies of cloned KATP channels
- Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies
- Sulfonylureas: a new look at old therapy
- Pharmacologic differences of sulfonylureas and the risk of adverse cardiovascular and hypoglycemic events
- Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
- Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke
- Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with …
- Antidiabetic sulfonylureas control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependent K+ channels.
- Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity-onset diabetes of the young
- The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta‐analysis
- Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes
- Effects on clinical outcomes of adding dipeptidyl peptidase-4 inhibitors versus sulfonylureas to metformin therapy in patients with type 2 diabetes mellitus
- sulfonylureas differ in effects on ischemic preconditioning—is it time to retire glyburide?
- Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas
- Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider
- Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
- Sulfonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle.
- The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas—a randomized trial
- … or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
- Sex and BMI alter the benefits and risks of sulfonylureas and thiazolidinediones in type 2 diabetes: a framework for evaluating stratification using routine clinical and …
- Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement
- Head‐to‐head comparison of dipeptidyl peptidase‐IV inhibitors and sulfonylureas–a meta‐analysis from randomized clinical trials
- Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas
- Pancreatic β-cell K ATP channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide
- Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction
- Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic β-cell line, MIN6
- Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
- Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas
- Combining sulfonylureas and other oral agents
- Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets
- KCNJ11 gene E23K variant and therapeutic response to sulfonylureas
- Association of hemoglobin A1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with type 2 diabetes treated with …
- The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents
- The efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with type 2 diabetes: a systematic review and meta …
- Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic β-cells
- Sulfonimidamide Analogs of Oncolytic Sulfonylureas,1
- Should sulfonylureas remain an acceptable first-line add-on to metformin therapy in patients with type 2 diabetes? No, it’s time to move on!
- Should sulfonylureas remain an acceptable first-line add-on to metformin therapy in patients with type 2 diabetes? Yes, they continue to serve us well!
- Sulfonylureas as initial treatment for type 2 diabetes and the risk of severe hypoglycemia
- Hypoglycemia in hospitalized patients treated with sulfonylureas
- Sulfonylureas have antifungal activity and are potent inhibitors of Candida albicans acetohydroxyacid synthase
- Sulfonylureas correct trafficking defects of ATP-sensitive potassium channels caused by mutations in the sulfonylurea receptor
- Defining a binding pocket for sulfonylureas in ATP‐sensitive potassium channels
- Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)
- Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas
- Antidiabetic sulfonylureas: localization of binding sites in the brain and effects on the hyperpolarization induced by anoxia in hippocampal slices
- TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes
- … in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas
- The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide
- Compliance with sulfonylureas in a health maintenance organization: a pharmacy record–based study
- Monotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas
- Anti-diabetic activity of Tinospora cordifolia (Willd.) in streptozotocin diabetic rats; does it act like sulfonylureas?
- Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies
- Sulfonylureas and risk of falls and fractures: a systematic review
- … detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas
- Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: a population‐based cohort study
- Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas
- Cerebrovascular Safety of Sulfonylureas: The Role of KATP Channels in Neuroprotection and the Risk of Stroke in Patients With Type 2 Diabetes
- Long-term effects of a diet loosely restricting carbohydrates on HbA1c levels, BMI and tapering of sulfonylureas in type 2 diabetes: a 2-year follow-up study
- Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective
- Cardiovascular effects of conventional sulfonylureas and glimepiride
- Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A
- ATP-sensitive K+ channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing …
- Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase C.
- Sulfonylureas: background and development of the field.
- All‐cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides
- Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas
- Pro-and antiarrhythmic actions of sulfonylureas: mechanistic and clinical evidence
- Pioglitazone and sulfonylureas: effectively treating type 2 diabetes
- Effects of sulfonylureas on tumor growth: a review of the literature
- Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor γ activity: a combined virtual screening and biological assay approach
- Preparation of Unsymmetrical Sulfonylureas from N,N’-Sulfuryldiimidazoles
- Sulfonylureas as concomitant insulin secretagogues and NLRP3 inflammasome inhibitors
- Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
- Sulfonylureas correct trafficking defects of disease-causing ATP-sensitive potassium channels by binding to the channel complex
- Multiple resistance to sulfonylureas and imidazolinones conferred by an acetohydroxyacid synthase gene with separate mutations for selective resistance
- Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides‐induced atrophy in skeletal muscle
- Dipeptidyl peptidase‐4 inhibitors and sulfonylureas for type 2 diabetes: friend or foe?
- Quantitative effects of glucose, sulfonylureas, salicylate, and indole-3-acetic acid on the secretion of insulin activity into pancreatic venous blood
- Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients.
- Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus
- Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
- Biguanides and sulfonylureas as combination therapy in NIDDM
- The benefits and risks of DPP 4‐inhibitors vs. sulfonylureas for patients with type 2 diabetes: accumulated evidence from randomised controlled trial
- Monotherapy with metformin versus sulfonylureas and risk of cancer in type 2 diabetic patients: a systematic review and meta-analysis
- Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas
- Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case‐control study
- Sulfonylureas: a new class of cancer chemotherapeutic agents
- Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysis
- Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide
- The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro
- Molecular basis of resistance to sulfonylureas in Papaver rhoeas
- … of glucose uptake and increased plasma membrane content of glucose transporters in L6 skeletal muscle cells by the sulfonylureas gliclazide and glyburide
- Sulfonylureas and cardiovascular safety: the final verdict?
- Real‐world weight change among patients treated with glucagon‐like peptide‐1 receptor agonist, dipeptidyl peptidase‐4 inhibitor and sulfonylureas for type 2 …
- Synthesis of some sulfonamides, disubstituted sulfonylureas or thioureas and some structurally related variants. A class of promising antitumor agents
- Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis
- Comparative safety of sulfonylureas and the risk of sudden cardiac arrest and ventricular arrhythmia
- Sulfonylureas and the risk of myocardial infarction
- Design, synthesis and herbicidal activity study of aryl 2, 6-disubstituted sulfonylureas as potent acetohydroxyacid synthase inhibitors
- Synthetic homoserine lactone-derived sulfonylureas as inhibitors of Vibrio fischeri quorum sensing regulator
- Identification and quantification of 8 sulfonylureas with clinical toxicology interest by liquid chromatography–ion-trap tandem mass spectrometry and library searching
- Antidiabetic Effects of Add-On Gynostemma pentaphyllum Extract Therapy with Sulfonylureas in Type 2 Diabetic Patients
- ATP-modulated K+ channels sensitive to antidiabetic sulfonylureas are present in adenohypophysis and are involved in growth hormone release.
- Antidiabetic medications in overdose: a comparison of the inquiries made to a regional poisons unit regarding sulfonylureas, biguanides and insulin.
- Cardiovascular benefits of acarbose vs sulfonylureas in patients with type 2 diabetes treated with metformin
- High-performance liquid chromatographic determination of sulfonylureas in soil and water
- Effects of thiazolidinediones and sulfonylureas in patients with diabetes
- Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction
- Metformin’s effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas
- Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits
- Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6. x subtypes
- Glucose both inhibits and stimulates insulin secretion from isolated pancreatic islets exposed to maximally effective concentrations of sulfonylureas
- Nonenzymatic glucosylation of human serum albumin and its influence on binding capacity of sulfonylureas
- Appraisal of the extrapancreatic actions of sulfonylureas
- … module of direct analysis in real time mass spectrometry for sensitive and high-throughput screening of illegally adulterated sulfonylureas in antidiabetic health-care …
- Design, synthesis and SAR study of novel sulfonylureas containing an alkenyl moiety
- Acetohydroxyacid synthase from Mycobacterium avium and its inhibition by sulfonylureas and imidazolinones
- Comparative safety of dipeptidyl peptidase-4 inhibitors versus sulfonylureas and other glucose-lowering therapies for three acute outcomes
- Hypoglycemic side effects of sulfonylureas and repaglinide in ageing patients-knowledge and self-management
- Fast capillary electrophoresis—ion spray mass spectrometric determination of sulfonylureas
- Cost-effectiveness analysis of metformin+ dipeptidyl peptidase-4 inhibitors compared to metformin+ sulfonylureas for treatment of type 2 diabetes
- Progressing from metformin to sulfonylureas or meglitinides
- … of a sulfonylurea-receptor-like protein in plants: modulation of stomatal movements and guard cell potassium channels by sulfonylureas and potassium channel …
- Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry
- Synthesis, structure–property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y12 receptor
- Risk of dementia in older patients with type 2 diabetes on dipeptidyl-peptidase IV inhibitors versus sulfonylureas: a real-world population-based cohort study
- Influence of pH and irradiation wavelength on the photochemical degradation of sulfonylureas
- The molecular interaction of sulfonylureas with β-cell ATP-sensitive K+-channels
- Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas
- Sodium-glucose co-transporter 2 inhibitors compared with sulfonylureas in patients with type 2 diabetes inadequately controlled on metformin: a meta-analysis of …
- Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population‐based follow‐up study
- QSAR and 3D‐QSAR analysis of structurally diverse ALS inhibitors: sulfonylureas and triazolopyrimidine‐2‐sulfonamides
- The effects of sulfonylureas plus metformin on lipids, blood pressure, and adverse events in type 2 diabetes: a meta-analysis of randomized controlled trials
- A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus
- The combination of DPP-4 inhibitors versus sulfonylureas with metformin after failure of first-line treatment in the risk for major cardiovascular events and death
- Reduced Intracerebral Hemorrhage and Perihematomal Edema Volumes in Diabetics on Sulfonylureas: A Case-Control Study
- The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients
- Precision Medicine: Long-Term Treatment with Sulfonylureas in Patients with Neonatal Diabetes Due to KCNJ11 Mutations
- Hypoglycemia-induced myocardial infarction: an unusual adverse effect of sulfonylureas
- Influence of straw management, nitrogen fertilization and dosage rates on the dissipation of five sulfonylureas in soil
- Identification of sulfonylureas in serum by electrospray mass spectrometry
- ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas
- Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy
- Effects of pioglitazone and metformin on vascular endothelial function in patients with type 2 diabetes treated with sulfonylureas
- Sulfonylureas and on-clopidogrel platelet reactivity in type 2 diabetes mellitus patients
- Sulfonylureas rapidly cross phospholipid bilayer membranes by a free-diffusion mechanism
- Sulfonylureas inhibit cytokine-induced eosinophil survival and activation
- Binding of sulfonylureas to serum proteins
- Effects of sulfonylureas on peroxisome proliferator-activated receptor γ activity and on glucose uptake by thiazolidinediones
- Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (Imidazolylbiphenylyl) …
- The infamous, famous sulfonylureas and cardiovascular safety: much ado about nothing?
- Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding to its receptors in target cells
- The use of glyburide compared with other sulfonylureas and the risk of cancer in patients with type 2 diabetes
- Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus
- Serious hypoglycemia and use of warfarin in combination with sulfonylureas or metformin
- CYP2C9* 2 allele increases risk for hypoglycemia in POR* 1/* 1 type 2 diabetic patients treated with sulfonylureas
- Sulfonylureas: basic aspects and clinical uses
- Intracellular targets for antidiabetic sulfonylureas and potassium channel openers
- Adenosine triphosphate levels of mammalian pancreatic B cells after stimulation with glucose and hypoglycemic sulfonylureas
- Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino) alkyl] benzoic acids
- Prodrug forms for the sulfonamide group. I. Evaluation of N-acyl derivatives, N-sulfonylamidines, N-sulfonylsulfilimines and sulfonylureas as possible prodrug …
- Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in …
- Sulfonylureas blockade of neural and cardiac HERG channels
- Sulfonylureas attenuate electrocardiographic ST-segment elevation during an acute myocardial infarction in diabetics
- The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis
- The Effect of Insulin Treatment on HbA1c, Body Weight and Lipids in Type 2 Diabetic Patients with Secondary-Failure to Sulfonylureas.
- Photochemistry of sulfonamides and sulfonylureas: A contribution to the problem of light‐induced dermatoses
- Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles
- Blockade of the antinociception induced by diclofenac, but not of indomethacin, by sulfonylureas and biguanides
- Carboxylic acid bioisosteres acylsulfonamides, acylsulfamides, and sulfonylureas as novel antagonists of the CXCR2 receptor
- The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: a cohort study
- Hydrogen‐isotope exchange (HIE) reactions of secondary and tertiary sulfonamides and sulfonylureas with iridium (I) catalysts
- The TOSCA. IT trial: a study designed to evaluate the effect of pioglitazone versus sulfonylureas on cardiovascular disease in type 2 diabetes
- Hypoglycemia induced by antidiabetic sulfonylureas
- Sulfonylureas: do we need to introspect safety again?
- Coadministration of co-trimoxazole with sulfonylureas: hypoglycemia events and pattern of use
- How do sulfonylureas approach their receptor in the B-cell plasma membrane?
- Design, synthesis and bioactivity of novel herbicides targeted ALS (VII): Quantitative structure‐activity relationships of herbicidal sulfonylureas
- Comparison of two sulfonylureas with high and low myocardial KATP channel affinity on myocardial infarct size and metabolism in a rat model of type 2 …
- Polymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes
- Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus
- The hypoglycemic sulfonylureas glyburide and tolbutamide inhibit fatty acid oxidation by inhibiting carnitine palmitoyltransferase.
- Incidence of new coronary events in older persons with diabetes mellitus and prior myocardial infarction treated with sulfonylureas, insulin, metformin, and diet alone
- Antidiabetic effects of dipeptidyl peptidase–IV inhibitors and sulfonylureas in streptozotocin-nicotinamide–induced mildly diabetic mice
- Genetic variations in TCF7L2 influence therapeutic response to sulfonylureas in Indian diabetics
- Comparing medication adherence and persistence among patients with type 2 diabetes using sodium-glucose cotransporter 2 inhibitors or sulfonylureas
- Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction
- Evaluation of the in vitro and intracellular efficacy of new monosubstituted sulfonylureas against extensively drug-resistant tuberculosis
- Misunderstandings and controversies about the insulin-secreting properties of antidiabetic sulfonylureas
- Interaction of sulfonylureas with liver uptake transporters OATP1B1 and OATP1B3
- Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta‐analysis of randomized controlled trials
- Sulfonylureas suppress the stimulatory action of Mg-nucleotides on Kir6.2/SUR1 but not Kir6.2/SUR2A KATP channels: A mechanistic study
- Interaction of sulfonylureas with pancreatic β-cells: a study with glyburide
- Effects of sulfonylureas on mitochondrial ATP‐sensitive K+ channels in cardiac myocytes: implications for sulfonylurea controversy
- Glucocrinology of modern sulfonylureas: Clinical evidence and practice-based opinion from an international expert group
- Standardized procedure for the assay and identification of hypoglycemic sulfonylureas in human plasma
- Glucose-dependent and glucose-sensitizing insulinotropic effect of nateglinide: comparison to sulfonylureas and repaglinide
- The second-generation sulfonylureas: change or progress?
- Are sulfonylureas less desirable than DPP-4 inhibitors as add-on to metformin in the treatment of type 2 diabetes?
- Efficacy and tolerability of acarbose in Asian patients with type 2 diabetes inadequately controlled with diet and sulfonylureas
- Clinical pharmacology of sulfonylureas
- Pharmacoepidemiologic and in vitro evaluation of potential drug–drug interactions of sulfonylureas with fibrates and statins
- The structure–activity relationship in herbicidal monosubstituted sulfonylureas
- Efficient Synthesis, Characterization, and Antibacterial Activity of Novel N-Acylsulfonamides and Sulfonylureas
- Trial for transdermal administration of sulfonylureas
- A facile synthesis of sulfonylureas via water assisted preparation of carbamates
- Dose‐response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes
- Adsorption of sulfonylureas onto activated charcoal in vitro
- A safety and tolerability profile comparison between dipeptidyl peptidase-4 inhibitors and sulfonylureas in diabetic patients: A systematic review and meta-analysis
- Failure of sulfonylureas to suppress plasma glucagon in man
- Permanent neonatal diabetes mellitus due to KCNJ11 mutation in a Portuguese family: transition from insulin to oral sulfonylureas
- The Stimulus‐Secretion Coupling of Glucose‐Induced Insulin Release VIII. Combined Effects of Glucose and Sulfonylureas
- Glucose and sulfonylureas modify different phases of the membrane potential change during hypoxia in rat hippocampal slices
- Combination therapy with insulin and sulfonylureas for type II diabetes
- Determination of sulfonylureas in cereal samples with electrophoretic method using ionic liquid with dispersed carbon nanotubes as electrophoretic buffer
- Early transition from insulin to sulfonylureas in neonatal diabetes and follow‐up: Experience from China
- Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure
- Cardiovascular effects of pioglitazone or sulfonylureas according to pretreatment risk: moving toward personalized care
- … of a potassium conductance in rat midbrain dopamine neurons by intracellular adenosine triphosphate (ATP) and the sulfonylureas tolbutamide and glibenclamide
- Warm-up’phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas
- Sulfonylureas: Effects in vivo and in vitro
- WITHDRAWN: A comprehensive structure–activity analysis of 5-Carboxyl Imidazolyl biphenyl Sulfonylureas derivatives angiotensin AT1 receptor antagonists: 2D-and …
- Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a-/-Model
- Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group
- Comparative effect of initiating metformin versus sulfonylureas on breast cancer risk in older women
- The stimulus-secretion coupling of glucose-induced insulin release—XVII: effects of sulfonylureas and diazoxide on insular biosynthetic activity
- Initiation of sulfonylureas versus metformin is associated with higher blood pressure at one year
- Evaluation of the efficacy and tolerability of miglitol in Chinese patients with type 2 diabetes mellitus inadequately controlled by diet and sulfonylureas
- Role of two adjacent cytoplasmic tyrosine residues in MRP1 (ABCC1) transport activity and sensitivity to sulfonylureas
- Nateglinide and mitiglinide, but not sulfonylureas, induce insulin secretion through a mechanism mediated by calcium release from endoplasmic reticulum
- Sulfonylureas and platelet function
- The pancreatic β-cell recognition of insulin secretagogues: IV. islet uptake of sulfonylureas
- Long-term comparison of oral hypoglycemic agents in diabetic retinopathy Gliclazide vs. other sulfonylureas
- Hormone-regulated K+ channels in follicle-enclosed oocytes are activated by vasorelaxing K+ channel openers and blocked by antidiabetic sulfonylureas.
- Second-generation sulfonylureas preserve inhibition of mitochondrial permeability transition by the mitochondrial K+ ATP opener nicorandil in experimental …
- Sulfonylureas: new high potency herbicides
- Sulfonylureas uncouple glucose-dependence for GPR40-mediated enhancement of insulin secretion from INS-1E cells
- Cost‐Effectiveness Analysis of Thiazolidinediones in Uncontrolled Type 2 Diabetic Patients Receiving Sulfonylureas and Metformin in Thailand
- Targeting of the Virulence Factor Acetohydroxyacid Synthase by Sulfonylureas Results in Inhibition of Intramacrophagic Multiplication of Brucella suis
- Persistence of sulfonylureas in Pullman clay loam
- Effects of feeding and fasting on the insulin secretory response to glucose and sulfonylureas in intact rats and isolated perfused rat pancreas
- Long-acting sulfonylureas–long-acting hypoglycaemia
- Coordinate regulation of glucose transporter function, number, and gene expression by insulin and sulfonylureas in L6 rat skeletal muscle cells.
- Frequencyof Severe Hypoglycemia in Patients with Non-Insulin Dependent Diabetes Mellitus Treated with Sulfonylureas or Insulin
- Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part II-“The cons”
- Sulfonylureas in the treatment of diabetes mellitus—1985
- Selective synthesis of sulfonylureas and carboxysulfamides a novel route to oxazolidinones.
- The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual …
- Hepatic effect of sulfonylureas
- Are sulfonylureas passé?
- Metabolic, cationic and secretory effects of hypoglycemic sulfonylureas in pancreatic islets
- Hydroxyl-substituted sulfonylureas as potent inhibitors of specific [3H] glyburide binding to rat brain synaptosomes
- Comparative single‐dose kinetics and effects of four sulfonylureas in healthy volunteers
- Direct measurements of increased free cytoplasmic Ca2+ in mouse pancreatic β-cells following stimulation by hypoglycemie sulfonylureas
- Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control
- Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas
- The mass spectrometry of sulfonylureas. I. Mechanisms for the loss of sulfur dioxide
- Sulfonylureas in insulin-dependent (type I) diabetes: evidence for an extrapancreatic effect in vivo
- Retrospective comparison of voglibose or acarbose as an add-on therapy to sulfonylureas in Western Indian patients with uncontrolled overweight/obese type 2 …
- Liquid chromatography mass/spectrometry multiresidue determination of sulfonylureas after on‐line trace enrichment
- Oral hypoglycemic agents: Sulfonylureas and meglitinides
- Effects of the sulfonylureas on muscle glucose homeostasis
- Sulfonylureas inhibit metabolic flux through rat liver pyruvate carboxylase reaction.
- Ineffectiveness of sulfonylureas in alloxan diabetic rats.
- Hypoglycemic action of sulfonylureas in patients with diabetes mellitus
- Sulfonylureas do not affect insulin binding or glycemic control in insulin-dependent diabetics
- Extractable insulin of the pancreas and effectiveness of oral hypoglycaemic sulfonylureas in the treatment of diabetes in man; a comparison.
- Mortality and cardiovascular risk of sulfonylureas in South Asian, Chinese and other Canadians with diabetes
- Sulfonylureas activate glucose transport and protein kinase C in rat adipocytes
- Prostanoid-induced contractions are blocked by sulfonylureas
- Metabolism of antidiabetic sulfonylureas in man: I. Biological half-lives of the p-acetylbenzenesulfonylureas, U-18536 and acetohexamide and their metabolites
- Evaluation of the in vivo efficacy of novel monosubstituted sulfonylureas against H37Rv and extensively drug-resistant tuberculosis
- Sulfonylureas and mortality in diabetic patients after myocardial infarction
- Differential sensitivity of plant and yeast MRP (ABCC)-mediated organic anion transport processes towards sulfonylureas
- Studies of the mode of action of the sulfonylureas and phenylacetamides in enhancing the effect of vasopressin
- A screening test for detecting sulfonylureas in plasma
- Interactions of sulfonylureas with plasma proteins
- Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: results from the DIMORA study
- Sulfonylureas stimulate glucose uptake through GLUT4 transporter translocation in rat skeletal muscle
- Three-dimensional quantitative structure− activity relationship analysis of the new potent sulfonylureas using comparative molecular similarity indices analysis
- Sulfonylureas and the heart
- Ion channel effects of antidiabetic sulfonylureas
- Effects of sulfonylureas, α-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes
- Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
- Synthesis of heterocyclic sulfonylureas
- Usage pattern, glycemic improvement, hypoglycemia, and body mass index changes with sulfonylureas in real-life clinical practice: results from OBSTACLE …
- … ) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia …
- A short series of antidiabetic sulfonylureas exhibit multiple ligand PPARγ-binding patterns
- Disturbances in autoregulatory responses of rat pial arteries by sulfonylureas
- Ionophoretic activity of hypoglycemic sulfonylureas.
- Screening and simultaneous quantitative measurement of six sulfonylureas in serum by liquid chromatography/mass spectrometry with atmospheric-pressure …
- Are physicians neglecting the risk of heart failure in diabetic patients who are receiving sulfonylureas? Lessons from the TOSCA. IT trial.
- Quantitative liquid chromatography of sulfonylureas in pharmaceutical products
- Operative Condition–Dependent Response of Cardiac ATP-Sensitive K+ Channels Toward Sulfonylureas
- … with highly charged polyelectrolytes and carbon nanotubes co-aggregated with sodium dodecyl sulphate for the analysis of sulfonylureas by capillary electrophoresis
- Regulation of cloned ATP-sensitive K channels by adenine nucleotides and sulfonylureas: interactions between SUR1 and positively charged domains on Kir6. 2
- Assay of sulfonylureas in human plasma by high-performance liquid chromatography
- Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat
- Biosynthesis of proinsulin and insulin in newborn rat pancreas. Interaction of glucose, cyclic AMP, somatostatin, and sulfonylureas on the (3H) leucine incorporation …
- Novel benzothiazole based sulfonylureas/sulfonylthioureas: design, synthesis and evaluation of their antidiabetic potential
- Synthesis and resolution of sulfonimidamide analogs of sulfonylureas
- A convenient synthesis of sulfonylureas from carboxylic acids and sulfonamides via an in situ Curtius rearrangement
- Binding study of sulfonylureas and phenothiazines to bovine serum albumin using difference spectrophotometry
- Long-term experience with sulfonylureas and placebo
- Acid and glucose-6-phosphatase activity of pancreatic B cells after cortisone and sulfonylureas.
- Potentiation of hypoglycemic effect of sulfonylureas by halofenate
- Balanced AT1 and AT2 angiotensin II antagonists. I. New orally active 5-carboxyl imidazolyl biphenyl sulfonylureas
- Effect of sulfonylureas on triglyceride metabolism in the rat liver: possible role of the lysosomes in hepatic lipolysis.
- Sulfonylureas and hypoglycemia
- Kir6.2 E23K polymorphism is related to secondary failure of sulfonylureas in non‐obese patients with type 2 diabetes
- Synthesis, characterization and in vitro antimicrobial activity of novel sulfonylureas of 15-membered azalides
- Dual actions of sulfonylureas and glyburide: Receptor and post-receptor effects
- Diabetes care for patients experiencing homelessness: beyond metformin and sulfonylureas
- Carnitine transport and its inhibition by sulfonylureas in human kidney proximal tubular epithelial cells
- … between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and …
- DEND syndrome due to V59A mutation in KCNJ11 gene: unresponsive to sulfonylureas
- Effects of sulfonylureas on the synthesis and secretion of plasminogen activator from bovine aortic endothelial cells.
- Assessment of the effects of sulfonylureas herbicide amidosulfuron application on target and non-target organisms.
- Influence of sulfonylureas on the secretion, disposal and effect of insulin
- Drug-induced desensitization of insulinotropic actions of sulfonylureas
- A mutation confers Monochoria vaginalis resistance to sulfonylureas that target acetolactate synthase
- Spermicidal activity of sulfonylureas and meglitinide analogues: role of intrasperm Ca2+ elevation
- Sulfonylureas and meglitinides: historical and contemporary issues.
- Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts
- Fasiglifam/TAK-875, a selective GPR40 agonist, improves hyperglycemia in rats unresponsive to sulfonylureas and acts additively with sulfonylureas
- Sulfonylureas as Dual Acting Agents—Synthesis and Biological Activity
- Bedtime insulin added to daytime sulfonylureas improves glycemic control in uncontrolled type II diabetes
- Effect of sulfonylureas administered centrally on the blood glucose level in immobilization stress model
- Long-Term Actions of Sulfonylureas on (Pro-) Insulin Biosynthesis and Secretion-I. Lack of Evidence for a Compensatory Increase in (Pro-) Insulin Biosynthesis After …
- Extrapancreatic effects of sulfonylureas: Potentiation of insulin action through post-binding mechanisms
- Counterpoint: a diabetes outcome progression trial (ADOPT): good for sulfonylureas?
- Measurement of antidiabetic sulfonylureas in serum by gas chromatography with electron-capture detection
- Design, synthesis and herbicidal activity of novel sulfonylureas containing triazole and oxadiazole moieties
- Reactions with 1-benzotriazolecarboxylic acid chloride. V Synthesis of sulfonylureas and related compounds
- Effects of sulfonylureas on membrane-bound low Km cyclic AMP phosphodiesterase in rat fat cells
- Different sulfonylureas induce the apoptosis of proximal tubular epithelial cell differently via closing KATP channel
- Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment
- Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages
- Research on the structure/activity relationship of herbicidal sulfonylureas
- Inhibitory effect of sulfonylureas on protein phosphatase activity in rat pancreatic islets
- On the possible role of thiol groups in the insulin-releasing action of mercurials, organic disulfides, alkylating agents, and sulfonylureas
- Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureas
- Mode of action of sulfonylureas
- Determination of sulfonylureas and metabolites by pyrolysis gas chromatography
- Chiral recognition of pinacidil and its 3-pyridyl isomer by canine cardiac and smooth muscle: antagonism by sulfonylureas.
- Sulfonylureas: New high potency herbicides
- Low-dose rosiglitazone (RSG) provides additional glycemic control when combined with sulfonylureas in type 2 diabetes (T2D)
- Effect of sulfonylureas on hepatic glycogen metabolism: Activation of glycogen phosphorylase
- Heterogeneity of the inhibitory influence of sulfonylureas on prostanoid-induced smooth muscle contraction
- Effects of sulfonylureas on left ventricular mass in type 2 diabetic patients
- Third‐line agent selection for patients with type 2 diabetes mellitus uncontrolled with sulfonylureas and metformin
- Synergistic interaction between metformin and sulfonylureas on diclofenac-induced antinociception measured using the formalin test in rats
- Factors associated with physicians’ decision to discontinue or down-titrate sulfonylureas for type 2 diabetes patients
- Effects of sulfonylureas on KATP channel-dependent vasodilation
- Sulfonylureas in the prevention of vascular complications: from UKPDS to the ADVANCE study
- Abuse of sulfonylureas: Is factitious hypoglycemia a cause for concern?
- Metabolic effects of hypoglycemic sulfonylureas—II: In vitro effect of sulfonylureas on cell-free protein synthesis and energy metabolism in rat tissues
- Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents
- Synthesis and herbicidal activity of novel sulfonylureas containing thiadiazol moiety
- Comparison of metabolism and toxicity to the structure of the anticancer agent sulofenur and related sulfonylureas
- Effect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): comparison of twice-daily biphasic insulin aspart 30 with or without …
- Inhibition of catecholamine release by tolbutamide and other sulfonylureas
- Effects of sulfonylureas on histochemical and ultracytochemical calcium distribution in B-cells of mice
- Exploring the distribution of prescription for sulfonylureas in patients with type 2 diabetes according to cardiovascular risk factors within a Canadian primary …
- Interaction of the Cytosolic Domains of the Kir6.2 Subunit of the KATP Channel Is Modulated by Sulfonylureas
- Sulfonylureas: Assets in the past, present and future
- Effect of sulfonylureas on hepatic fatty acid oxidation
- Effects of sulfonylureas on the pancreas
- The Reaction of Sulfonylureas and Sulfonamides with Carbonyl Chloride. A New Synthesis of Isocyanates1
- Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptor
- The impact of sulfonylureas on hepatic glucose metabolism in type II diabetics.
- Homologous and hybrid calcium complexes of A23187 and hypoglycemic sulfonylureas: nuclear magnetic resonance and conformational analysis
- Analysis of the sulfonylurea herbicide metsulfuron-methyl and its metabolites in the soil of cereal crops. Comparative analytical chemistry of the sulfonylureas
- Antihypertensive drug therapy and hypoglycemia in elderly diabetic patients treated with insulin and/or sulfonylureas
- Processing and transport of insulin by vascular endothelial cells: effects of sulfonylureas on insulin receptors
- Synthesis and pharmacology of pyrid-3-yl sulfonylureas and thioureas as astrocytic Na+ 2C1− K+ cotransporter inhibitors
- Original Articles; Inhibition of Acetohydroxyacid Synthase by Sulfonylureas and Imidazolinones
- Augmentation of the effects of insulin and insulin-like growth factors I and II on glucose uptake in cultured rat skeletal muscle cells by sulfonylureas
- Therapeutic aspects of sulfonylureas: a brief review
- Thermal Dissociation of Sulfonylureas II: Dissociation of Four N-and N′-Substituted Sulfonylureas in Different Media
- Hypoglycemic Sulfonylureas Antagonize the Effects of Cromakalim and Pinacidil on 86Rb Fluxes and Contractile Activity in the Rat Aorta
- Sulfonylureas enhance in vivo the effectiveness of insulin in type 1 (insulin dependent) diabetes mellitus
- Extrapancreatic action of sulfonylureas: hypoglycemic effects are not dependent on altered insulin binding or inhibition of transglutaminase
- Conjugates of degraded and oxidized hydroxyethyl starch and sulfonylureas: Synthesis, characterization, and in vivo antidiabetic activity
- Inositol hexakisphosphate and sulfonylureas regulate β-cell protein phosphatases
- Effects of sulfonylureas on adipocyte and skeletal muscle insulin action in patients with non-insulin-dependent diabetes mellitus
- Dose-response relationships of sulfonylureas: will doubling the dose double the response?
- Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in …
- Pharmacogenomics of Sulfonylureas response in relation to rs7754840 Polymorphisms in Cyclin-Dependent Kinase 5 regulatory subunit-associated protein 1 …
- Within-class differences of the sulfonylureas should be accounted for
- Clinical pharmacology of sulfonylureas
- Synthesis and biological evaluation of sulfonylcyanoguanidines and sulfonamidonitroethylenes as bioisosteres of hypoglycemic sulfonylureas
- Uncoupling action of sulfonylureas on brown fat cells
- Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes?
- Design, syntheses and biological activity of novel ALS inhibitors (IX) CoMFA of sulfonylureas and triazolopyrimidine-2-sulfonamides ALS inhibitors
- Pyrolysis—gas chromatography/mass spectrometry and electron impact-, fast atom bombardment-mass spectrometry of sulfonylureas
- Comparison of the effects of three sulfonylureas on in vivo insulin action
- Focus on repaglinide: an oral hypoglycemic agent with a more rapid onset and shorter duration of action than the sulfonylureas
- Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy
- Relaxant effects of sulfonylureas on induced contractions of rat uterine smooth muscle: role of intracellular calcium.
- Pancreatic action of the sulfonylureas
- Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
- Extrapancreatic effects of hypoglycemic sulfonylureas: still a controversial issue
- Antidiabetic sulfonylureas relax isolated rabbit coronary arteries
- Metabolic effects of hypoglycemic sulfonylureas—I: In vitro effect of sulfonylureas on leucine incorporation and metabolism and on respiration of rat tissues
- Teratogenic effects of sulfonylureas and insulin in rats
- Sulfonylureas and related compounds
- Oral sulfonylureas for the treatment of type II diabetes: an update.
- Modern Sulfonylureas Strike Back–Exploring the Freedom of Flexibility
- Effects of biguanides and sulfonylureas on insulin receptors in cultured cells.
- The Positive Inotropic Action of Sulfonylureas: A Mechanism Independent of Cyclic Adenosine 3′, 5′-Monophosphate
- Long-Term Actions of Sulfonylureas on (Pro-) Insulin Biosynthesis and Secretion-II. Studies after Administration of Tolbutamide and Glibenclamide to Rats In Vivo
- A kinetic study of the methanolysis of the sulfonylureas bensulfuron methyl and sulfometuron methyl using capillary electrophoresis
- Syntheses and tissue distribution of 99mTc-sulfonylureas
- Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas?
- Metabolic effects of hypoglycemic sulfonylureas—V: In vitro effects of sulfonylureas on mitochondrial adenosine triphosphatase activity
- Lack of Ca2+ ionophoretic activity of hypoglycemic sulfonylureas in excitable cells and isolated secretory granules
- Lipids behavior and adverse effects for oral antidiabetic agents in patients with type2 diabetes treated with sulfonylureas alone based on systematic review
- Permeation of Sulfonylureas through Cellulose and Dimethylpolysiloxane Membranes
- A strategy of chemical control of Apera spica-venti L. resistant to sulfonylureas traced on the molecular level
- Regulation of muscle fructose 2, 6-bisphosphate levels by sulfonylureas
- Design, syntheses and biological activities of novel sulfonylureas containing an oxime ether moiety
- Effects of sulfonylureas on the actions of insulin and insulin-mimickers: potentiation of stimulated hexose transport in adipocytes
- Ischemia in type 2 diabetes: tissue selectivity of sulfonylureas and clinical implications
- Do hypoglycemic sulfonylureas inhibit Na+, K+-ATPase activity in pancreatic islets?
- Analysis of secondary failure to sulfonylureas in type 2 diabetics. A retrospective study for 1976–1987
- Glucagon and growth hormone secretion in insulin-treated diabetics: effects of added sulfonylureas
- Combination of insulin and sulfonylureas: a literature review
- Transport of Pr3+ by hypoglycemic sulfonylureas across liposomal membranes
- Sulfonylureas and meglitinides: insights into physiology and translational clinical utility
- Displacement of sulfonylureas from human serum proteins by coumarin derivatives and cortical steroids
- Synthesis and molecular modeling of novel non-sulfonylureas as hypoglycemic agents and selective ALR2 inhibitors
- Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus
- Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany
- Capillary electrophoretic behavior of seven sulfonylureas.
- A Radioimmunoassay for Determination of Glibenclamide and Other Sulfonylureas
- Silent hypoglycaemic episodes among well controlled type 2 diabetic patients treated with sulfonylureas
- Metabolic effects of hypoglycemic sulfonylureas—IV: Interference of sulfonylureas with mitochondrial oxidative phosphorylation
- Pharmacodynamic herb-drug interactions: the effects of Azadirachta indica leaf extracts on two commonly used second generation sulfonylureas
- Effects of chronic and acute treatment with sulfonylureas on plama insulin and glucose levels in the rat.
- Prediction of therapeutic doses of sulfonylureas based on receptor occupancy theory
- Synthesis and herbicidal activity of sulfonylureas; SL-950 and its related compounds
- Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide
- Preparation of Some Additional Sulfonylureas.
- Effect of sulfonylureas on the permeability to water and electrical properties of the urinary bladder of the toad
- Thermal dissociation of sulfonylureas: Dissociation of tolbutamide in a series of aliphatic alcohols and in polyethylene glycol 400
- Observations of the mechanism of action of the sulfonylureas under clinical conditions
- Sulfonylureas mimic glucose in stimulating the uptake of Na+ in pancreatic islets exposed to ouabain
- Metabolic effects of sulfonylureas in normal men and in various types of diabetic patients
- … A (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia …
- Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of …
- Synthesis and herbicidal activity of sulfonylureas with fused heterocyclic moiety
- Balanced AT1 and AT2 angiotensin II antagonists. II. Potent 5 α-hydroxyacid imidazolyl biphenyl sulfonylureas
- Sulfonylureas as treatment choice in Diabetes Mellitus: Where are we now?
- Interaction of sulfonylureas with the transport of bile acids into hepatocytes
- Metabolic effects of hypoglycemic sulfonylureas—III: Effect of chlorpropam1de on energy metabolism and ketogenesis in the isolated perfused rat liver
- Effect of hypoglycemic sulfonylureas on hepatic fructose metabolism in the rat
- Evidence for more than one binding site for sulfonylureas in insulin‐secreting cells
- Evaluation of first-generation sulfonylureas and glipizide in non-insulin-dependent diabetes mellitus
- Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas
- Potential impact of sulfonylureas in the outcome of type 2 diabetic patients with ischemic stroke
- Do sulfonylureas still have a role in type 2 diabetes?
- Role of Sulfonylureas in Non-Insulin-Dependent Diabetes Mellitus: Part I-“The pros”
- Does mortality risk vary among sulfonylureas?
- Sulfonylureas as second line treatment for type 2 diabetes
- O-Dealkylation of coumarin ethers and effects of inducers, inhibitors, and sulfonylureas on rice cytochrome P-450
- Comparative Effects of Three Sulfonylureas (Glibenclamide, Glimepiride, and Gliclazide) on Proliferation and Migration of Vascular Smooth Muscle Cells.
- Respiration of the β-cells in the presence of sulfonylureas
- Clinical pharmacokinetics of sulfonylureas: a brief review.
- New fluoro intermediates for herbicidal sulfonylureas
- A study of the possible interaction of indoprofen with hypoglycemic sulfonylureas in diabetic patients.
- Synthesis and Herbicidal Activities of Sulfonylureas Bearing 1, 3, 4‐Thiadiazole Moiety
- Chemical control of branched broomrape in processing tomato using sulfonylureas in Southern Italy
- Comparative risk for cardiovascular diseases of dipeptidyl peptidase-4 inhibitors vs. sulfonylureas in combination with metformin: results of a two-phase study
- Persistence of sulfonylureas on alkaline soils in south-eastern Australia and the potential damage to subsequent crops and pastures
- Transcription factor 7-like 2 rs7903146 polymorphism and therapeutic response to sulfonylureas in patients with type 2 diabetes
- On the stability of zwitterions of pyridine sulfonylureas: the effect of isosterism, acidity, and microsolvation
- Sulfonylureas activate glycogen phosphorylase and increase cytosolic free-Ca2+ levels in isolated rat hepatocytes
- The clinical effects of levosimendan are not attenuated by sulfonylureas
- A 12-h Intravenous Insulin Infusion Restores the [beta]-Cell Response Torpidity to Sulfonylureas in Patients Affected by Type 2 Diabetes
- Microvascular permeability with sulfonylureas in normal and diabetic hamsters
- Synthesis and herbicidal activities of pyridyl sulfonylureas: More convenient preparation process of phenyl pyrimidylcarbamates
- Therapeutic benefit of benfluorex in type II diabetic patients treated with sulfonylureas
- Study on the bioactivity changes of hydroxylated sulfonylureas derivatives: A possible metabolism
- Effects of sulfonylureas (tolbutamide, glipentide and glibenclamide) on in vitro glycerol metabolism in adipose tissue from rats
- Stoichiometry of calcium binding by hypoglycemic sulfonylureas.
- Design, synthesis and bioactivity of novel ALS inhibitors (V) Initial model of the herbicidal sulfonylureas and fused heterocyclic sulfonamides binding with receptor
- Comparing the effect of dipeptidyl-peptidase 4 inhibitors and sulfonylureas on albuminuria in patients with newly diagnosed type 2 diabetes mellitus: A prospective …
- Clinical characteristics influencing the effectiveness of metformin on Japanese type 2 diabetes receiving sulfonylureas
- … or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
- Combined therapy with glibenclamide and ultralente insulin in lean patients with NIDDM with secondary failure of sulfonylureas. Follow up at two years.
- Effectiveness of Nateglinide on In Vitro Insulin Secretion from Rat Pancreatic Islets Desensitized to Sulfonylureas
- International diabetes federation meeting, 1997: Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone
- Metformin combined with dipeptidyl peptidase-4 inhibitors or metformin combined with sulfonylureas in patients with type 2 diabetes: a real world analysis of the South …
- Hyaluronidase-induced inhibition of the insulinotropic action of sulfonylureas, leucine, and glucagon in rodent isolated pancreatic islets
- Risk factors associated with treatment discontinuation and down-titration in type 2 diabetes patients treated with sulfonylureas
- Effects of oral sulfonylureas on the spectrum of defects in non-insulin-dependent diabetes mellitus
- Possible approaches to CYP2C9-guided prescription of sulfonylureas in Russia
- Factors moderating the effect of oral sulfonylureas on free water clearance
- The synthesis of some new sulfonylureas
- Effect of CYP2C9 gene polymorphisms on response to treatment with sulfonylureas in a cohort of Egyptian type 2 diabetes mellitus patients
- Sulfonylureas and ischemic heart disease
- Theoretical study on conformation-related activity of hypoglycemic sulfonylureas
- Modulation of glucose metabolism by sulfonylureas in primary cultures of adult rat hepatocytes.
- Balanced AT1 and AT2 angiotensin II antagonists. III. potent and orally active 5-β-ketosulfoxide imidazolyl biphenyl sulfonylureas
- Severe hypoglycemia by combination therapy with dipeptidyl peptidase-4 (DPP-4) inhibitors and sulfonylureas
- Synergistic effect of hypoglycemic sulfonylureas and negative phospholipids on calcium transport: ionic and conformational aspects.
- Simple and effective preparation of amino sulfonylureas from amino acids: application to the synthesis of amino sulfonylurea-containing peptidomimetics
- Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
- Effects of sulfonylureas on patients with type 2 diabetes and acute nonlacunar ischemic stroke
- … cardiometabolic risk factors in overweight/obese patients with poorly controlled type 2 diabetes (HbA (1c)>= 8%) on monotherapy with metformin or sulfonylureas
- Thiazolidinedione use is associated with improved all-cause mortality compared with sulfonylureas among diabetic hemodialysis patients
- Sulfonylureas, Science and Serendipity
- Continue with long term sulfonylureas in patients with mutations in the KCNJ11 gene when there is evidence of response even if insulin treatment is still required
- Hypertension in type 2 diabetes mellitus: do we need to redefine the role of sulfonylureas?
- Synthesis and herbicidal activity of 1, 4‐benzoxazin‐3‐one sulfonylureas
- Vinylogous sulfonylureas: a new class of acetohydroxyacid synthase inhibitors incorporating a large bridging moiety
- Effects of cations, ionophores and hypoglycemic sulfonylureas on the fluorescence of fluorescein-labelled pancreatic islets.
- Antidiabetic sulfonylureas modulate farnesoid X receptor activation and target gene transcription
- Blockers of sulfonylureas receptor 1 subunits may lead to cardiac protection against isoprenaline-induced injury in obese rats
- Six-month effectiveness and tolerability of pioglitazone in combination with sulfonylureas or metformin for the treatment of type 2 diabetes mellitus
- Sulfonylureas—a novel treatment to reduce tissue damage after acute spinal cord injury?
- Sulfonylureas: physico-chemical properties, analytical methods of determination and bioavailability
- Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma
- Metabolic effects of hypoglycemic sulfonylureas—VI: Effects of chlorpropamide and carbutamide on ketogenesis and on mitochondrial redox state in the isolated …
- Current status of aryl sulfonylureas in treatment of diabetes mellitus
- Risk and benefit of sulfonylureas–their role in view of new treatment options for type 2 diabetes
- Simultaneous high performance liquid chromatography determination of three sulfonylureas in plasma
- How important is the synclinal conformation of sulfonylureas to explain the inhibition of AHAS: a theoretical study
- Sulfonylureas and heart disease in diabetes management
- Comparing the Efficacy of Amicarbazone, a Triazolinone, with Sulfonylureas forWeed Control inMaize (Zea mays)
- Exploring clinical care among adults with diabetes mellitus: alignment with recommended statin and sulfonylureas treatment
- New Pyrazole Sulfonylureas: Synthesis and Herbicidal Activity
- Decreased responsiveness of gluconeogenesis to the modulation by sulfonylureas in hepatocytes isolated from obese (fa/fa) Zucker rats
- MIR4532 gene variant rs60432575 influences the expression of KCNJ11 and the sulfonylureas-stimulated insulin secretion
- Effect of hypoglycemic sulfonylureas on Ca2+ fluxes across lipid bilayers
- Phytotoxicity of amidosulfuron (sulfonylureas herbicide) to aquatic macrophyte Lemna minor L.
- Synthesis and herbicidal activity of bicyclic Sulfonylureas
- Sulfonylureas stimulate renin secretion from the perfused kidney of the rat
- Suppression by 2-ketoisocaproate of the insulinotropic action of hypoglycemic sulfonylureas.
- Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas
- Sulfonylureas induced hypoglycemia in diabetics-a
- Antidiabetic sulfonylureas antagonize somatostatin inhibition of prolactin secretion in vitro
- Molecularly imprinted ‘traps’ for sulfonylureas prepared using polymerisable ion pairs
- Impact of Switching from Sulfonylureas to Dipeptidyl Peptidase-4 Inhibitors on Hypoglycemia Burden in the United States—A Predictive Modeling Approach
- Tissue distribution and metabolism of drugs VI: Effect of second drugs on pancreatic distribution and insulin‐releasing activity of sulfonylureas in perfused rat pancreas
- Sulfonylureas and cardiovascular mortality in diabetes: a class effect?
- Cardiovascular Profile of Modern Sulfonylureas: Focus on Glimepiride
- Synthesis, crystal structure and herbicidal activity of novel sulfonylureas containing triazolinone moiety
- Synthesis and herbicidal activity of conformationally restricted butyrolactone sulfonylureas
- … , ADHERENCE AND THEIR ASSOCIATIONS WITH GLYCEMIC GOALS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH SULFONYLUREAS
- The effect of sulfonylureas on the respiratory quotient in diabetic and normal animals
- … of anti-diabetic therapy on overweight/obesity and dyslipidemia: traditional hypoglycemic agents (metformin, sulfonylureas, thiazolidinediones) versus glucagon-like …
- Clinical Pharmacology of Sulfonylureas
- Sulfonylureas in today’s blood glucose lowering therapy. New data on advantages and potential barriers of an “old” antidiabetic group
- Supercritical fluid extraction of sulfonylureas from aqueous matrices
- 1H nuclear magnetic resonance and clinical studies of interaction of calcium antagonists and hypoglycemic sulfonylureas
- Design, synthesis and herbicidal activity of novel sulfonylureas containing tetrahydrophthalimide substructure
- Supratherapeutic doses of sulfonylureas in diabetic patients: How much is too much?
- Diet only or diet and sulfonylureas in mild type II diabetes (NIDDM)? Pathophysiologic and therapeutic implications
- Review of safety considerations in the elderly using sulfonylureas
- Neuroglycopenic Seizures: Sulfonylureas, Sulfamethoxazole, or Both?
- Sulfonylureas and annual medic regeneration on high pH soils
- Efficacy and safety of premixed human insulin combined with sulfonylureas in type 2 diabetic patients previously poorly controlled with insulin
- Selectivity of sulfonylureas in seed crops of perennial ryegrass (Lolium perenne L.).
- Sulfonylureas in type 2 diabetes mellitus: current evidence, conflicts and clinical implications
- Warfarin with sulfonylureas and hypoglycemic events: consider dose, length of treatment, and all sulfonylureas
- Combination therapy of metformin vs dipeptidulpeptidase inhibitors and sulfonylureas in type 2 diabetes: clinical and economic impact
- Combination Use of Sulfonylureas and Insulin in the Treatment of Noninsulin‐Dependent Diabetes Mellitus
- Diabetes mellitus and ischemic cardiopathy: potential effects of the use of sulfonylureas
- Influence of long-term used herbicides on resistance development in Apera spica-venti L. to sulfonylureas.
- Ethnic variations in the risk of hypoglycaemia among people with Type 2 diabetes prescribed insulins and/or sulfonylureas: a historical cohort study using general …
- Sulfonylureas in the therapy of type 2 diabetes mellitus: where do we stand today?
- Not all sulfonylureas persist for the same time
- Stimulation of biliary glutathione secretion by sulfonylureas.
- Healthcare resource use and associated costs of hypoglycemia in patients with type 2 diabetes prescribed sulfonylureas
- Oral sulfonylureas and CV mortality.
- The clinical use of oral sulfonylureas in the management of non-insulin dependent diabetes mellitus (NIDDM).
- Comment on Genuth. Should sulfonylureas remain an acceptable first-line add-on to metformin therapy in patients with type 2 diabetes? No, it’s time to move on …
- Comparison in Rabbits of Hypoglycemia and B Cell Degranulation After Various Sulfonylureas.
- A new mesangial triumvirate: Sulfonylureas, their receptors and endosulfines
- Evolution of Sulfonylureas: Commentary on Developmental Process and Initial Trials
- Binding of sulfonylureas to serum albumin: A response
- Conformational analysis of Sulfonylureas
- Improving management of type 2 diabetes mellitus: 3. Sulfonylureas
- Synthesis of flavone‐3‐sulfonylureas
- Synthesis and herbicidal activity of novel sulfonylureas containing 1, 2, 4-triazolinone moiety
- The effects of long-term administration of sulfonylureas on the carbohydrate metabolism in normal and alloxanized rats; have sulfonylureas a diabetogenic action?
- Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular …
- Effect of herbicide combinations on biotypes of wind bentgrass (Apera spica-venti) sensitive and resistant to sulfonylureas [Conference poster].
- Protein Binding of Sulfonylureas. I. Interaction of Some Substituted Benzenesulfonyl Propylureas to Bovine Serum Albumin
- Failure of sulfonylureas in type 2 diabetes
- PROGRESS REPORT OF AMERICAN DIABETES ASSOCIATION ON ORALLY EFFECTIVE HYPOGLYCEMIC SULFONYLUREAS: GUEST EDITORIAL
- Sulfonylureas Amplify Cyclic 3′, 5′ AMP Mediated Hormone Action
- Rational use of sulfonylureas
- Antibacterial Activity of Novel Sulfonylureas, Ureas and Thioureas of 15-Membered Azalides
- Sulfonylureas Having Diuretic Activity
- Quantitative effects of glucose, sulfonylureas, salicylate, and indole-3-acetic acid on the secretion of insulin activity into pancreatic venous blood.
- Economic effect of augmentation strategies in patients with type 2 diabetes initiated on sulfonylureas.
- Sulfonylureas in the treatment of type II diabetes
- Effects of D-glucose during preincubation of pancreatic islets with 45Ca upon the subsequent stimulation of 45Ca outflow by hypoglycemic sulfonylureas and K+.
- Patient and prescriber characteristics among patients with type 2 diabetes mellitus continuing or discontinuing sulfonylureas following insulin initiation: data from a …
- Sulfonylureas and daily blood glucose profiles in elderly diabetics
- Sulfonylureas or dipeptidyl peptidase (DPP-4) inhibitors in the management of type 2 diabetes: debate is not yet closed
- Comparison of Insulin, Sulfonylurea and Sulfonylureas-Metformin Combination on HbA1c and eGFR Level on Age-, Sex-and BMI-Matched Groups of …
- Does insulin+ sulfonylureas= effective treatment of NIDDM?
- Study on the vascular effects of chronic administration of two sulfonylureas, chlorpropamide and glibenclamide, on the healthy rat thoracic aorta
- The Risk of Mortality Varies Amongst Sulfonylureas: A Meta-analysis of Controlled Studies
- A quantum chemical study with special reference to the sulfamyl group of sulfonylureas
- Long-Term Actions of Sulfonylureas on (Pro-) Insulin Biosynthesis and Secretion
- Response to Comment on Genuth. Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? No, It’s …
- The place of sulfonylureas in the modern treatment of type 2 diabetes mellitus: The end of an era or the beginning of a new one?
- Inhibitory effects of sulfonylureas and non‐steroidal anti‐inflammatory drugs on in vitro metabolism of canagliflozin in human liver microsomes
- Sulfonylureas at the glomerular battlefield
- Metformin and Sulfonylureas Effect on the Blood Level of Prostate Specific Antigen
- Precision medicine with sulfonylureas: from clinical studies to bedside practice
- CONSUMPTION ANALYSIS OF METFORMIN, SULFONYLUREAS, AND OTHER ANTIDIABETICS DRUGS IN MOROCCO (1991-2005)
- Possible Interaction Of Pantoprazole On Sulfonylureas In Diabetic Rats
- A study on the safety and injury of sulfonylureas herbicides to cereal crops
- SULFONYLUREAS AND THE HEART¹
- DPP-4 inhibitors show benefits over sulfonylureas as add-on diabetes therapy
- Should diabetic patients treated long-term with sulfonylureas be switched to nateglinide?
- … ) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia …
- Sensitivity of kochia (Kochia scoparia [L.] Schrader) from three localities to selected sulfonylureas, imazapyr and atrazine.
- Severe hypoglycemia caused by Sulfonylureas and Biguanides in a patient with obstructive anuria: Resolution with ureteral stent
- Reaction of sulfonylureas with methanol
- Risk of heart failure in diabetic patients receiving sulfonylureas
- Hypoglycemic adverse reactions to insulin and sulfonylureas.
- Beyond sulfonylureas: new oral medications in the treatment of NIDDM (Type II DM)
- Metabolites of hypoglycemic sulfonylureas in kidney failure. Experience with glibenclamide
- Intensification of Metformin treatment in diabetic patients with Insulin versus Sulfonylureas
- Kinetics-effect relations of glipizide and other sulfonylureas.
- Insulin vs Sulfonylureas for Second-Line Diabetes Treatment
- Glycogen phosphorylase activities in sulfonylureas treated rats
- The effect of hypoglycemic sulfonylureas on human red blood cell transglutaminase activity
- Pharmacogenetics of sulfonylureas
- Economic burden of type 2 diabetes mellitus treatment strategies: A cost consequence analysis of sitagliptin vs sulfonylureas in Lombardy region
- Effects of epinephrine and glucose on the in vitro response of adipose tissue to sulfonylureas
- Effects of different sulfonylureas on the warm-up phenomenon in diabetes patients with coronary artery disease
- Insulin responses to sulfonylureas
- Synthesis and herbicidal activity of novel 4-substituted pyrimidinyl-phenyl-sulfonylureas
- … of an Oral Antidiabetic Agent Experimental Studies: Extractable Insulin of the Pancreas and Effectiveness of Oral Hypoglycæmic Sulfonylureas in the Treatment of …
- Sulfonylureas: Asset or liability?
- Time to be cautious about prescribing sulfonylureas?
- Sulfonylureas and Related Compounds
- Can sulfonylureas induce cardiotoxicity?
- The second generation sulfonylureas: glipizide and glyburide
- Synthesis of sulfonylureas containing 1, 15-pentadecanolide ring
- Pre-Meal and Post-Meal Use of Humalog [R] Mix25 [TM] in Elderly Patients with Type 2 Diabetes and Oral Treatment Inadequacy with Sulfonylureas
- Short-term intensive insulin therapy as a method of overcoming secondary failure of sulfonylureas in patients with type 2 diabetes (non-insulin-dependent)
- The 32nd Annual Meeting of the European Association for the Study of Diabetes. Leptin, insulin resistance, intrauterine malnutrition, sulfonylureas, oral agents alone …
- Protein Binding of Sulfonylureas. II. Interaction of Some p-Toluenesulfonyl-n-alkylureas with Bovine Serum Albumin
- A clinical study of the sulfonylureas in diabetes.
- Synthesis of novel herbicidal sulfonylureas
- In patients with type 2 diabetes who are maximized on metformin with HbA1C above 7%, are GLP-1 agonists more effective than sulfonylureas for lowering HbA1C?
- HOMA as a Predictor of Insulin Requirement in Type 2 Diabetes with Apparent Secondary Sulfonylureas Failure
- WITHDRAWN: Structural insights for 5-β-Ketosulfoxide Imidazolyl Biphenyl Sulfonylureas derivatives as angiotensin II AT1 receptor antagonists using kNN-MFA with …
- Effect of chronic hyperglycemia on islet# beta# cells function in type 2 diabetes mellitus with secondary sulfonylureas failure
- Short-term intensive insulin treatment and sensitivity of sulfonylureas
- Patients with Type 2 Diabetes on Sulfonylureas Exhibit Significantly Less Neurological Impairment on Admission with First Ever Acute Stroke.
- The use of DPP-4 inhibitors versus sulfonylureas as second line therapy in combination with metformin for treatment of Diabetes Mellitus type II
- Statistical Analysis of Sulfonamide Allergy Item Annotation in Drug Instructions of Commonly-used Sulfonylureas at Home and Abroad
- … , Ogston SA, Emslie-Smith A, Morris AD: Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas …
- Risk of CV disorders with insulin or sulfonylureas
- Variation in TCF7L2 Influences Glycemic Response to Sulfonylureas.
- Exploring the role of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus.
- Glucagon-Like Peptide-1S compared to Sulfonylureas in the Treatment of Adults Diagnosed with Type II Diabetes Mellintus in Primary Care
- Reply to the letter by P. Guillausseau Regarding “Sulfonylureas or Dipeptidyl Peptidase (DPP-4) Inhibitors in the Management of Type 2 Diabetes: Debate Is Not Yet …
- … DISEASE-RELATED HOSPITALIZATION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE BID, SULFONYLUREAS, OR INSULIN: A …
- COMPARATIVE SAFETY OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS AND SULFONYLUREAS IN OLDER ADULTS ACROSS LEVELS OF FRAILTY
- Preadmission treatment with sulfonylureas and infarct size after ST-elevation myocardial infarction
- Sulfonylureas dosage: from therapeutic monitoring to differential diagnosis of hyperinsulinism
- … of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes: How to Escalate Therapy for Patients who Fail Sulfonylureas
- Sulfonylureas show unfavourable risk profiles
- Within-class differences of the sulfonylureas should be accounted for. Reply to Schrijnders D, Kleefstra N and Landman GWD
- Conformational Analysis of Sulfonylureas: Acetohexamide and Tolazamide
- The Safety Profile Comparison Between Dipeptidyl Peptidase-4 Inhibitors and Sulfonylureas in Diabetic Patients: A Systematic Review and Meta-Analysis
- Sulfonylureas associated with hypoglycaemia
- A Systematic Review and Network Meta-Analysis Assessing the Effectiveness and Tolerability of Gliptins and Sulfonylureas as Monotherapy in Patients with Type 2 …
- Sulfonylureas attenuate electrocardiographic ST-segment elevation during an acute myocardial infarction in diabetics
- The Use of Sulfonylureas in the Treatment of Adult Onset Diabetes
- Who comes in second? The race against sulfonylureas and DPP4s as add-on therapy
- CONTROL OF HEPATIC GLUCOSE METABOLISM BY ORAL HYPOGLYCEMIC SULFONYLUREAS.
- Balancing Risks in the Choice of Medications for Diabetics with Alcohol Use Disorders: Physicians Prefer Insulin and Sulfonylureas.
- 474 Hypoglycemic Agents Sulfonylureas Constrict the Fetal Ductus Arteriosus in the Rat
- Influence of sulfonylureas on cardiovascular system: progress in basic research and clinical research
- Huizar JF, Gonzalez LA, Alderman J, Smith HS: Sulfonylureas attenuate electrocardiographic ST-segment elevation during an acute myocardial infarction in diabetics
- Glycemic Effects Linked to Unique Mechanism of Action of Sulfonylureas
- Different Therapeutic Regimens for Diabetic Patients with Sulfonylureas Secondary Failure: Cost-Effectiveness Analyses and Evaluation of Life Quality
- … or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis”
- Blockade of the antinociception induced by diclofenac, but not of indomethacin, by sulfonylureas and biguanides
- Comparative Effectiveness between Dipeptidylpeptidase-4 Inhibitors and Sulfonylureas in Combination with Metformin in Type 2 Diabetes Mellitus Patients
- Permeation of sulfonylureas through cellulose and dimethylpolysiloxane membranes.
- Sulfonylureas increase cancer risk
- Cardiovascular safety of DPP-4 inhibitors compared to that of sulfonylureas
- Effect of therapy with insulin or sulfonylureas on lipid levels in patients with NIDDM
- Circular dichroism studies on the interaction of sulfonylureas with insulin
- Concurrent Use of Sulfonylureas and Antimicrobials of the Elderly in Korea: A Potential Risk of Hypoglycemia
- Sulfonylureas are associated with a higher adjusted risk of myocardial infarction compared to metformin in patients with type 2 diabetes
- Blockade of the antinociception induced by diclofenac, but not of indomethacin, by sulfonylureas and biguanides
- Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus
- Effects of troglitazone in patients with type 2 diabetes mellitus not adequately controlled by sulfonylureas
- Synthesis of some sulfonylureas of potential herbicidal activity
- Warfarin+ sulfonylureas: serious hypoglycaemic events
- Some Doubts About the Mantra on the Deleterious Cardiovascular Effects of Sulfonylureas
- Effects of sulfonylureas (Tolbutamide, Glipentide and Glibenclanide) on in vitro glycerol metabolism in adipose tissue from rats.
- SGLT2 inhibitors cost effective versus sulfonylureas in T2DM
- The Effects of Long-term Administration of Sulfonylureas on the Carbohydrate Metabolism in Normal and Alloxanized Rats; Have Sulfonylureas a Diabetogenic Action …
- Risk of Cardiovascuar Disease in Type 2 Diabetic Women on Sulfonylureas: A Retrospective Case-Control Study
- Effects of glucose and sulfonylureas on Ca (2+) entry and the sodium content of pancreatic islets.
- Sulfonylureas and Glinides Exhibit PPARγ Activity: A Combined Virtual Screening and Biological Assay Approach
- SULFONYLUREAS AND ON-TREATMENT PLATELET REACTIVITY IN TYPE 2 DIABETES MELLITUS PATIENTS
- Glucose controls glucagon secretion with minor changes in alpha cell [Ca2+] c whereas sulfonylureas control glucagon secretion by increasing alpha cell [Ca2+] c …
- Protonophoretic activity of hypoglycemic sulfonylureas in black lipid membranes
- SULFONYLUREAS AND GLINIDES AS NEW PPARγ AGONISTS: VIRTUAL SCREENING AND BIOLOGICAL ASSAYS
- Pharmacovigilance‐pharmacological investigations on sulfonylureas and glinides‐induced atrophy in skeletal muscle (1142.5)
- Cost-effectiveness Analysis of Three Sulfonylureas in Treatment of Noninsulin Dependent Diabetes Mellitus
- Sulfonylureas and cardiovascular effects: From the laboratory to the bedside, clinical data and implications in man
- Simultaneous high performance liquid chromatography determination of three sulfonylureas in plasma
- Metformin in Combination With Dipeptidyl Peptidase-4 Inhibitors or Sulfonylureas in The Treatment of Type 2 Diabetes: Clinical And Economic Impact
- Sulfonylureas in specific clinical situations: maturity onset diabetes of the young (MODY)
- At low glucose arginine stimulates and sulfonylureas or K+ depolarization inhibit glucagon secretion by perifused mouse islets
- … ; Moon, So Young; Han, Seung Jin. Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors versus Sulfonylureas: A Real-World …
- Fasting insulin levels correlate with the incidence of hypoglycemic events in patients with Type 2 Diabetes treated with sulfonylureas: a retrospective cross-sectional …
- The concurrent use of sulfonylureas & nicorandil: risk or benefit
- Histological Changes in Normal and Alloxanized Rats with Prolonged Administration of Sulfonylureas
- … COST-EFFECTIVENESS ANALYSIS OF METFORMIN COMBINED WITH SAXAGLIPTIN VERSUS METFORMIN COMBINED WITH SULFONYLUREAS IN TYPE-2 …
- Cardiovascular safety perceptions of sulfonylureas based on evidence
- Building Evidence to Assess a Drug Safety Signal: the Association between Sulfonylureas and Adverse Cardiovascular Events
- … : Large-scale Meta-analysis of Diverse Ancestry Genome-wide Association Studies to Identify Pharmacogenomic Interactions of Sulfonylureas and ECG Phenotypes
- Dosing schedule of second generation sulfonylureas in the treatment of non-insulin dependent diabetes should be revised (A commentary)
- Reborn the controversy related with the use of sulfonylureas
- Prevalence of Physiological, Pathological and Behavioral Risk Factors in Patients Treated with Antidiabetic Sulfonylureas
- Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes
- Effect of treatment and change of islet function by adding insulin glargine on patients with second failure of sulfonylureas
- Severity & Extent Of Myocardial Infarction In Diabetic Patient Taking Insulin & Sulfonylureas
- Therapeutic Review of Metformin and Sulfonylureas Regimen for Protection of Cardiac Autonomic Neuropathy in Type 2 Diabetes Mellitus
- Synthesis and Herbicidal Activity of Sulfonylureas with Fused Heterocyclic Moiety
- Inhibitory effect of sulfonylureas on protein phosphatase activity in rat pancreatic islets.
- Correlation entre la circulation coronarienne et les modifications observees sur l’ECG orthogonal (French text, sulfonylureas)
- Study of the LADA prevalence among diabetics with secondary sulfonylureas failure
- Cost-Effectiveness of Sulfonylureas versus Metformin as First-Line Therapy in Newly Diagnosed Type 2 Diabetes.
- 142-LB: First Non-sulfonylurea Type Inhibitors of SUR1 Showed Superior Efficacy over Sulfonylureas, and Reversed Sulfonylurea Failure
- Clinical implication of serum insulin determination. Diagnosis and prognosis in patients with apparent secondary failure of treatment with sulfonylureas (author’s transl)
- Kunte H, Schmidt S, Eliasziw M, del Zoppo GJ, Simard JM, Masuhr F, Weih M, Dirnagl U: Sulfonylureas improve outcome in patients with type 2 diabetes and acute …
- Investigations on the Antilipolytic Activity of Sulfonylureas in Man with Indications on Limit Dosages Concerning their Insulin-Secreting Properties
- Hypoglycemia associated with concurrent use of commonly used sulfonylureas and warfarin, an observational analysis
- Syntheses and Tissue Distribution of ggmTc-Sulfonylureas
- Do sulfonylureas imply a resistance risk in Scandinavia?
- Effect of metformin and pioglitazone on serum albumin binding of selected sulfonylureas
- Interest of adjuvants and some contact herbicides in tank mix with grassweeds sulfonylureas.
- Study of the impact of water hardness on grass weeds control with sulfonylureas.
- N1, N3-diarly sulfonylureas as possible anticancer agents
- SULFONYLUREAS; NEW HIGH POTENCY
- Islets Desensitized to Sulfonylureas In Vitro Retain Responsiveness to Nateglinide but Not Repaglinide
- Study of the impact of ferrous ions (Fe2+) concentration and pH on grass weeds control with sulfonylureas.
- Type 2 Diabetes: Cardiovascular Outcomes with Metformin and Incretin Combination Therapy Compared to Metformin and Sulfonylureas
- Sodium handling by the pancreatic beta-cell: Effects of glucose, sulfonylureas and neuroreceptor agonists.
- If not sulfonylureas, then what?
- Real world adherence benefits from combination products utilized in diabetics: Sulfonylureas & metformin
- INHIBITION OF FATTY ACID OXIDATION BY SULFONYLUREAS
- Physician Reported Reasons for discontinuing or down-Titrating Sulfonylureas In type 2 Diabetes Patients
- Effects of epinphrine and glucose on the in vitro response of adipose tissue to sulfonylureas.
- Sulfonylureas Are Associated With Elevated Risk Of Hip Fractures Among Elderly Men And Women With Type-2 Diabetes
- A MATHEMATICAL ANALYSIS OF THE BINDING OF THREE HYPOGLYCEMIC SULFONYLUREAS TO NORMAL AND ACETYLATED HUMAN SERUM ALBUMIN.
- Future perspective on pharmacogenomics of severe hypoglycemia associated with sulfonylureas: reply from the authors
- Sulfonylureas in the Management of Type II Diabetes Mellitus
- Insulin vs Sulfonylureas for Second-Line Diabetes Treatment
- Insulin vs Sulfonylureas for Second-Line Diabetes Treatment—Reply
- Insulin vs Sulfonylureas for Second-Line Diabetes Treatment—Reply
- Sulfonylureas—a novel treatment to reduce tissue damage after acute spinal cord injury?–Authors’ reply
- A Systematic Review on Hypoglycemia Rate Attributable to Sulfonylureas Utilization in Randomized Controlled Trials of SGLT2 Inhibitors
- 014 Impact of type of pre-admission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction
- Role Of Sulfonylureas In Perihematomal Edema In Spontaneous Intracerebral Hemorrhage (N8. 002)
- Changes in plasma amino acids levels and in vivo gluconeogenesis from alanine in rats chronically treated with sulfonylureas.
- Distribution of diuretics and hypoglycemic sulfonylureas in rabbit erythrocytes
- THE FIRST LINE DRUG IN HYPOGLYCEMIC THERAPY: METFORMIN OR SULFONYLUREAS?
- Sulfonylureas in Type 2 Diabetes: A Case Discussion
- sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group. Pharmacogenomics Journal
- Antihypertensives and the Risk of Serious Hypoglycemia in Older Persons Using Insulin or Sulfonylureas
- Effects of imidazolinones and sulfonylureas on jimsonweed seed production and seedling emergence
- Effects of sulfonylureas on left ventricular mass in type
- Regulation of metabolic effects in L6 muscle cells by sulfonylureas and the protein tyrosine phosphatase inhibitors vanadate and pervanadate
- THE SYNTHESIS OF POTENTIAL HYPOGLYCEMIC SULFONYLUREAS
- Sulfonylureas: Physico-chemical Properties, Analytical Methods of Determination
- The effects of glucose, glucagon and sulfonylureas on insulin release from chicken pancreatic pieces
- SHOULD SULFONYLUREAS REMAIN THE DRUGS OF FIRST CHOICE IN ADDITION TO METFORMIN?
- Risk Factors Associated With Treatment Discontinuation and Down-titration in Type 2 Diabetes Patients Treated With Sulfonylureas
- Hypoglycemic Adverse Reactions to Insulin and Sulfonylureas
- The frequency of hypoglycemia and cardiovascular disorders during therapy with sulfonylureas compared with other secretagogues: a systematic review
- Investigating the effect of low-dose sulfonylureas on glucagon secretion in diabetes mellitus
- Synthesis and investigation of the physical properties of some related sulfonylureas
- Pharmacogenomics of Sulfonylureas and Glinides on ATP-Sensitive Potassium Channel
- Performance of DPP-4-inhhibitors versus sulfonylureas on top of metformin in a real world setting-results of 2 years FU of DiaRegis
- Sulfonylureas: Scoring beyond START STUDY
- Indications and methods of treatment with sulfonylureas in NIDDM patients
- Reply to the Letter to the Editor from van der Wal and Heine (Insulin responses to sulfonylureas)
- All-things Insulin, Metformin, GLP-1, Sulfonylureas
- SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?
- Synthesis and first evaluation of new 18F‐labelled sulfonylureas for the determination of the beta‐cell status in vivo
- PDB10 Effectiveness of Vildagliptin Compared to Sulfonylureas in Type 2 Diabetes Patients in Germany: Results From a Large Real-Life Cohort Study
- Popularity of Sulfonylureas in Real-World Practice: Perspective from Diabetes Forward
- Field soil dissipation of sulfonylureas-study design and results.
- … . Its revisions include a new chapter on the” finger-stick” method of self-glucose testing, along with reviews of the” second-generation” sulfonylureas and the use …
- … using tolbutamide and tolazamide in normal and diabetic subjects. Various aspects of the prolonged use of tolazamide in comparison with other sulfonylureas
- Budgetary Impact of Thiazolidinedione (TZD) Add-On Therapy Relative to Insulin (INS) Add-On Therapy in Individuals Treated with Sulfonylureas (SU): A Third Party …
- Studies on the metabolism of ketone bodies and pyruvic acid in patients with various endocrine disorders. 3. Effects of sulfonylureas, biguanides and insulin on the …
- Supplementary material A facile synthesis of Sulfonylureas via water assisted preparation of Carbamates
- Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in
- Additions and Corrections-Sulfonylureas Having Diuretic Activity
- Effects of sulfonylureas and clofibrate on insulin receptors in cultured human lymphocytes
- Effects of metformin and sulfonylureas on overall and colorectal cancer-specific mortality.
- Sulfonylureas trigger Ca2+-dependent Epac2 recruitment and Rap activation at the plasma membrane in β-cells
- Plasma Concentrations Of FAM3D Protein Is Higher In Individuals With Type 2 Diabetes Mellitus Treated With Sulfonylureas
- A patient on insulin plus sulfonylureas
- Two-Year Assessment of the Therapeutic Efficacy of Dipeptidyl Peptidase-4 Inhibitors or Sulfonylureas in Japanese Drug-Naive Patients With Type 2 Diabetes (JDDM …
- 1 A New Mesangial Triumvirate: Sulfonylureas, Their Receptors and Endosulfines
- 1. Supplementary a. Late Complications of Diabetes Mellitus: Risk Factors in Patients on Sulfonylureas for More than 10 Years
- PERFORMANCE OF DPP-4 INHHIBITORS VERSUS SULFONYLUREAS ON TOP OF METFORMIN IN A REAL WORLD SETTING: RESULTS OF TWO-YEAR FOLLOW …
- SWITCHING FROM INSULIN TO ORAL SULFONYLUREAS IN PATIENTS WITH PERMANENT NEONATAL DIABETES—CASE REPORT.
- Sulfonylureas Tied to Mortality in MI Survivors
- Sulfonylureas in permanent neonatal diabetes mellitus due to an activating mutation of Kir6. 2
- … insulin exocytosis through glucose sensing and drug signaling: With special focus on serine/threonine protein phosphates and hypoglycemic sulfonylureas
- Comparative embryotoxicological analysis of metformin (Biguanide) and glibenclamide (Sulfonylureas), using Zebrafish Embryotoxicity Test (ZFET)
- A novel approach to support evidence-based medicine: should sulfonylureas remain an acceptable therapy for diabetes?
- Sulfonylureas-a new dimension in weed control.
- Effectiveness of sulfonylureas against Orobanche sp. on tomato.
- Combined use of mineral fertilizers and sulfonylureas.
- Herbicides: Sulfonylureas
- Correction of pseudoresistance to sulfonylureas with amaryl
- Primary Intracerebral Hemorrhage and Perihematomal Edema Volumes in Diabetics on Sulfonylureas: a Case-Control Study (P1. 244)
- Design, synthesis and pharmacological evaluation of sulfonylureas and sulfonycyanoguanidines as thromboxane A2 receptor antagonists. Insights into selectivity …
- Mechanisms and characteristics of sulfonylureas and glinides
- The role of sulfonylureas in the treatment of type 2 diabetes
- Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
- Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: emulation of a target trial …
- Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events …
- Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors vs sulfonylureas in patients with type 2 diabetes
- The effect of CYP2C9 genotype variants in type 2 diabetes on the pharmacological effectiveness of sulfonylureas, diabetic retinopathy, and nephropathy
- Risk of cardiovascular outcomes in patients with type 2 diabetes after addition of SGLT2 inhibitors versus sulfonylureas to baseline GLP-1RA therapy
- Genome-wide meta-analysis identifies genetic variants associated with glycemic response to sulfonylureas
- Metformin is associated with a lower risk of atrial fibrillation and ventricular arrhythmias compared with sulfonylureas: an observational study
- Comparative safety of sodium–glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors and sulfonylureas on the risk of diabetic ketoacidosis
- Hospitalization for lactic acidosis among patients with reduced kidney function treated with metformin or sulfonylureas
- Comparative safety of dipeptidyl peptidase‐4 inhibitors and sulfonylureas among frail older adults
- Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study
- Comparison of Mitochondrial Adenosine Triphosphate–Sensitive Potassium Channel High-vs Low-Affinity Sulfonylureas and Cardiovascular Outcomes in Patients …
- Association Between Specificity of Sulfonylureas to Cardiac Mitochondrial KATP Channels and the Risk of Major Adverse Cardiovascular Events in Type 2 Diabetes
- Sulfonylureas and the risk of ventricular arrhythmias among people with type 2 diabetes: a systematic review of observational studies
- Broad-specific immunochromatography for simultaneous detection of various sulfonylureas in adulterated multi-herbal tea
- Effects of sulfonylureas on periodontopathic bacteria-induced inflammation
- Concomitant use of sulfonylureas and warfarin and the risk of severe hypoglycemia: population-based cohort study
- Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of …
- Hospitalization for heart failure among patients with diabetes mellitus and reduced kidney function treated with metformin versus sulfonylureas: a retrospective cohort …
- A polygenic score for type 2 diabetes risk is associated with both the acute and sustained response to sulfonylureas
- Glucose control, sulfonylureas, and insulin treatment in elderly people with type 2 diabetes and risk of severe hypoglycemia and death: an observational study
- Second-generation antidiabetic sulfonylureas inhibit Candida albicans and Candidalysin-mediated activation of the NLRP3 inflammasome
- Generation of sulfonylureas under photoredox catalysis and their biological evaluations
- Sulfonylureas use and fractures risk in elderly patients with type 2 diabetes mellitus: a meta-analysis study
- Comparative effect of metformin versus sulfonylureas with dementia and Parkinson’s disease risk in US patients over 50 with type 2 diabetes mellitus
- Cardioprotective effects of dipeptidyl peptidase-4 inhibitors versus sulfonylureas in addition to metformin: a nationwide cohort study of patients with type 2 diabetes
- Hypoglycemia associated with antibiotics alone and in combination with sulfonylureas and meglitinides: an epidemiologic surveillance study of the FDA Adverse …
- Complementary strategy enhancing broad-specificity for multiplexed immunoassay of adulterant sulfonylureas in functional food
- Synthesis and Pharmacological Evaluation of New N-Sulfonylureas as NLRP3 Inflammasome Inhibitors: Identification of a Hit Compound to Treat Gout
- Sulfonylureas for treatment of periodontitis-diabetes comorbidity-related complications: killing two birds with one stone
- Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: an experience with conceptual replication in two independent populations
- Sulfonylureas in the current practice of type 2 diabetes management: are they all the same? Consensus from the Gulf Cooperation Council (GCC) countries …
- Transformation of iodosulfuron-methyl into ionic liquids enables elimination of additional surfactants in commercial formulations of sulfonylureas
- Sulfonylureas or biguanides is associated with a lower risk of rheumatoid arthritis in patients with diabetes: A nationwide cohort study
- Photo-switchable sulfonylureas binding to ATP-sensitive potassium channel reveal the mechanism of light-controlled insulin release
- Hypoglycemia risk with SGLT2 inhibitors or glucagon-like peptide 1 receptor agonists versus sulfonylureas among medicare insured adults with CKD in the …
- Dipeptidyl peptidase-4 inhibitors and sulfonylureas prevent the progressive impairment of the nigrostriatal dopaminergic system induced by diabetes during aging
- Latest evidence on sulfonylureas: what’s new?
- Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
- Pretreatment of sulfonylureas reducing perihematomal edema in diabetic patients with basal ganglia hemorrhage: a retrospective case-control study
- Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study
- The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb …
- Relationship between glycated hemoglobin level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas: a multicenter cross‐sectional …
- The place of sulfonylureas in guidelines: why are there differences?
- Computer-assisted improvement of sulfonylureas with antifungal properties and limited herbicidal activity: potential application in forage conservation
- Recent advances in the synthesis of sulfonylureas
- Design, synthesis and biological evaluation of 5‑substituted sulfonylureas as novel antifungal agents targeting acetohydroxyacid synthase
- Effects of DPP‐4 inhibitors, GLP‐1 receptor agonists, SGLT‐2 inhibitors, and sulfonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: a …
- Pharmacogenomics of sulfonylureas in type 2 diabetes mellitus; a systematic review
- Studies of binding by sulfonylureas with glyoxal-and methylglyoxal-modified albumin by immunoextraction using affinity microcolumns
- Comment on Dawed et al. Genome-wide meta-analysis identifies genetic variants associated with glycemic response to sulfonylureas. Diabetes Care 2021; 44: 2673 …
- Position of sulfonylureas in the current ERA: Review of national and international guidelines
- Association of sulfonylureas with the risk of dementia: A population‐based cohort study
- Pharmacologic heterogeneity and risk of severe hypoglycemia with concomitant use of sulfonylureas and DPP‐4 inhibitors: population‐based cohort study
- One-Pot Synthesis of Thio-Augmented Sulfonylureas via a Modified Bunte’s Reaction
- Is it time to ban sulfonylureas?
- Association of Renal and Cardiovascular Safety With DPP‐4 Inhibitors vs. Sulfonylureas in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease
- Synthesis, herbicidal activity and soil degradation of novel 5‐substituted sulfonylureas as AHAS inhibitors
- Characterization of Binding by Sulfonylureas with Normal or Modified Human Serum Albumin using Affinity Microcolumns Prepared by Entrapment
- Comparative safety of sulfonylureas among US nursing home residents
- A potential role of calpains in sulfonylureas (SUs)–mediated death of human pancreatic cancer cells (1.2 B4)
- An Ultrasensitive Lateral Flow Immunoassay Based on Metal-Organic Framework-Decorated Polydopamine for Multiple Sulfonylureas Adulteration in Functional …
- Structure–Stability Relationship of NLRP3 Inflammasome-Inhibiting Sulfonylureas
- Sulfonylureas and metformin were not associated with an increased rate of serious bleeding in warfarin users: a self‐controlled case series study
- … to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021; 44 …
- COVID-19 and sulfonylureas: A reminder of the pleiotropic actions of an old class of drugs just before their swansong
- Outcomes in patients with aneurysmal subarachnoid hemorrhage receiving sulfonylureas: a propensity-adjusted analysis
- Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: a meta-analysis
- Risk of severe hypoglycemic events from amiodarone‐sulfonylureas interactions: a population‐based nested case‐control study
- A pharmacogenetic pilot study of CYP2C9 common genetic variant and sulfonylureas therapeutic response in type 2 diabetes mellitus patients
- Comparative effectiveness of metformin versus sulfonylureas on kidney function decline or death among patients with reduced kidney function: a retrospective cohort …
- Effect of berberine on in vitro metabolism of sulfonylureas: A herb–drug interactions study
- Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants
- Treatment Dynamics in People Who Initiate Metformin or Sulfonylureas for Type 2 Diabetes: A National Cohort Study
- A molecularly imprinted polymer for microextraction by packed sorbent of sulfonylureas herbicides from corn samples
- Chemical preparation, degradation analysis, computational docking and biological activities of novel sulfonylureas with 2, 5-disubstituted groups
- Dynamics of total volume of pancreatic α‐and β‐cells under the influence sulfonylureas and their combination with dipeptidyl peptidase‐4 inhibitors
- Efficacy and cardiovascular safety of sulfonylureas
- Cost-Utility analysis of dapagliflozin compared to sulfonylureas for type 2 diabetes as second-line treatment in Indian healthcare payer’s perspective
- Sulfonylureas as second line therapy for type 2 diabetes among veterans: Results from a National Longitudinal Cohort Study
- Is Gliclazide Associated with a Lower Obesity-Related Cancer Risk Compared to Other Sulfonylureas? A Long-term Prospective Cohort Study
- The Effectiveness and Safety of Metformin Compared to Sulfonylureas in Diabetic Nephropathy: A Systematic Review
- Effects of Co‐administration of Sulfonylureas and Antimicrobial Drugs on Hypoglycemia in Patients with Type 2 Diabetes Using a Case‐Crossover Design
- Metformin, Sulfonylureas, DPP-4 Inhibitors and Cardiovascular Outcomes in Type 2 DM
- Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
- Adding Sodium–Glucose Co-Transporter 2 Inhibitors to Sulfonylureas and Risk of Hypoglycemia: A Systematic Review and Meta-Analysis of Randomized …
- 125-LB: Individualized Cost-Effectiveness Assessment of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i) vs. Sulfonylureas as Add-On Therapy in People with …
- Cardiac mitoKATP channel high-affinity sulfonylureas were associated with an increased MACE risk compared with low-affinity sulfonylureas in a nationwide …
- Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase‐4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients
- Effects of Dipeptidyl Peptidase-4 Inhibitors and Sulfonylureas on Cognitive and Physical Function in Nursing Home Residents
- Effects of Remote Ischemic Preconditioning on Decreasing Troponin Release in Patients Not Taking Sulfonylureas After Cardiac Surgery–A Meta-Analysis
- Clinical review: Safety and efficacy comparison between sulfonylureas and dipeptidyl peptidase-4 inhibitors as second-line therapies in type 2 diabetes mellitus
- Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective …
- Adherence to Sulfonylureas in Comparison to Metformin among T2DM Patients: A Systematic Review and Meta-Analysis
- Sulfonylureas in the treatment of type 2 diabetes mellitus: a fresh look and new insights
- In Reply—Comparison of Outcomes With Metformin and Sulfonylureas in Chronic Kidney Disease
- KCNQ1 rs2237895 polymorphism is associated with the therapeutic response to sulfonylureas in Iranian type 2 diabetes mellitus patients
- Unravelling the utility of modern sulfonylureas from cardiovascular outcome trials and landmark trials: expert opinion from an international panel
- Sulfonylureas and Meglitinides
- The residual effect of metsulfuron on soybean tolerant and non-tolerant to sulfonylureas
- Sulfonylureas and meglitinides in the treatment of type 2 diabetes mellitus
- The place of sulfonylureas in the evolving landscape of combination therapy
- Hypoglycemia with insulin and sulfonylureas
- Cross sectional study on proportion of sulfonylureas among various oral antidiabetic drugs using for Japanese patients with type 2 diabetes, analyzed from NSAID …
- Concomitant use of sulfonylureas and beta-blockers and the risk of severe hypoglycemia: Population-based cohort study
- Dynamics of total volume of pancreatic α‐and β‐cells under the influence sulfonylureas and their combination with dipeptidyl peptidase‐4 inhibitors
- FC 125: Comparative Effectiveness of Dipeptidyl Peptidase-4 Inhibitors versus Sulfonylureas in Addition to Metformin: A Population-Based Cohort Study of Patients …
- Genetic Variants Associated with Poor Responsiveness to Sulfonylureas in Filipinos with Type 2 Diabetes Mellitus
- Comparative toxicological analysis of metformin (Biguanide) and glibenclamide (Sulfonylureas), using zebrafish embryotoxicity test (ZFET)
- Sulfonylureas target the neurovascular response to decrease Alzheimer’s pathology
- Sulfonylureas Use Is Not Associated With Increased Infarct Size in Patients With Type 2 Diabetes and ST-Segment Elevation Myocardial Infarction
- Risk of cardiovascular outcomes in type 2 diabetes patients following addition of SGLT2 inhibitors versus sulfonylureas to baseline GLP-IRA therapy
- In silico screening for inhibitory potentiality towards protein structure tyrosine phosphatase 1B of sulfonylureas derivatives
- Metformin and Other Sulfonylureas for Glycemic Control in Type 2 Diabetic Patients at a Tertiary Care Hospital in Jammu & Kashmir
- Effects of Sulfonylureas Treatment on Apoptosis, Total Superoxide Dismutase activity and Some Biochemical Parameters in Type 2 Diabetic Patients.
- Can Sulfonylureas for Agricultural Use Cause Diabetes? A Report of Three Cases
- We studied all 24 individuals with ABCC8-PNDM diagnosed in the UK, Italy, France, and US known to transfer from insulin to sulfonylureas before May 2010 …
- Effect of herbal drug supplementation in pharmacokinetics and pharmacodynamics of sulfonylureas.
- Fasting insulin levels correlate with the frequency of hypoglycemic events in people with type 2 diabetes on treatment with sulfonylureas: A pilot study
- Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes—Reply
- … safety and efficacy of combination therapy with metformin and sodium-glucose cotransporter-2 inhibitors versus metformin and sulfonylureas in patients with type 2 …
- Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes
- Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort …
- … -P: Distributional Cost-Effectiveness Analysis of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) and Tirzepatide Compared with Sulfonylureas (SU) in People …
- Determination of the ionization constants of sulfonylureas in THF–water media by potentiometric titration and RPLC methods
- RWD89 Risk of Electrolyte Imbalance in Elderly Colorectal Cancer Patients Following Treatment with Metformin Vs Sulfonylureas
- Investigation of concomitant use of Alzheimer’s disease drugs with sulfonylureas and serious hypoglycemia
- EPH3 Comparing Cardiac Safety Profile of Metformin and Sulfonylureas in Colorectal Cancer (CRC) Patients with Type 2 Diabetes Mellitus (T2DM): Surveillance …
- Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas: The Price of Prevention
- 35-OR: Risk of Cardiovascular Outcomes in Diabetes Patients following the Addition of SGLT2 Inhibitors vs. Sulfonylureas to Baseline GLP-1RA Therapy
- Comparison of Outcomes With Metformin and Sulfonylureas in Chronic Kidney Disease
- RWD116 Hospitalizations Among Patients with Both Colorectal Cancer and Type II Diabetes Mellitus Treated with Metformin Vs. Sulfonylureas: A Seer-Medicare …
- Sulfonylureas and the Risk of Ventricular Arrhythmias Among Patients with Type 2 Diabetes
- High Concurrent Use of Sulfonylureas and Antimicrobials With Drug Interactions Causing Hypoglycemia
- Computational studies sulfonylureas molecules
- Cardiovascular Safety of SGLT2 Inhibitors Compared to DPP4 Inhibitors and Sulfonylureas as the Second-Line of Therapy in T2DM Using Large, Real-World Clinical …
- “Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care”
- Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021; 44: 2673–2682
- Comparison of Efficacy of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled with Metformin; A …
- Response to Letter to the Editor:“Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care”
- 1136-P: A Population-Based Assessment of the Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and Peptidomimetic Dipeptidyl Peptidase-4 …
- Comparison of Safety and Economic Burden of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled with …
- 302 Outcomes in Aneurysmal Subarachnoid Hemorrhage Patients with Diabetes on Sulfonylureas: A Propensity Match Analysis
- Sulfonylureas and Mortality Risk
- … endocrine cells ratio in the pancreas of rats with type 2 diabetes mellitus following long-term therapy with incretin mimetics and their combination with sulfonylureas …
- Second-generation Sulfonylureas
- … Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas
- Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin …
- Molecular Docking of Sulfonylureas to the SUR1 Receptor
- A Review on Drug Related Problems in Type 2 DM with Combination of Sulfonylureas and Biguanides
- … Neonatal Diabetes Mellitus (NDM) in Two Siblings Who Also Carry a Second Inactivating Mutation: Genetic Testing Allows for Improved Treatment With Sulfonylureas …
- Effects of sulfonylureas, α-endosulfine counterparts, on Effects of sulfonylureas,-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of …
- THE EFFECT OF SULFONYLUREAS DRUGS ON KIDNEY AND LIVER FUNCTIONS IN TYPE 2 DIABETIC PATIENTS
- 2209-PUB: Factors Associated with Switching from Sulfonylureas (SUs) to Dipeptidyl Peptidase-4 Inhibitors (DPP-4i) among Individuals with Type 2 Diabetes in the …
- Genome-Wide Meta-Analysis Identifies the Organic Anion-Transporting Polypeptide Gene SLCO1B1 and Statins as Modifiers of Glycemic Response to Sulfonylureas
- 1976-P: Cardiovascular Safety of Sulfonylureas in Type 2 Diabetes: Effect Modification by Obesity?
- Simultaneous determination of three sulfonylureas herbicides froms environmental samples by HPLC-DAD
- 1414-P: Characteristics Associated with Sulfonylureas and Basal Insulin Use following Metformin in Older Adults
- Hospitalizations for Heart Failure Among Patients With Reduced Renal Function Treated With Metformin or Sulfonylureas: A Retrospective Cohort Study
